Selective Inhibition of Topoisomerase I and Various Steps of Spliceosome Assembly by Diospyrin Derivatives

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Molecular Pharmacology

• Publication date

  2005-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1124/MOL.104.007633PMID 15625279
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Manipulation of Alternative Splicing by a Newly Developed Inhibitor of Clks*

  2004cited by this paper
• Targeting DNA and Topoisomerase I with Indolocarbazole Antitumor Agents

  2004cited by this paper
• Alternative splicing in disease and therapy

  2004cited by this paper
• Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts

  2003cited by this paper
• Altered serine/arginine-rich protein phosphorylation and exonic enhancer-dependent splicing in Mammalian cells lacking topoisomerase I.

  2003cited by this paper
• Non-camptothecin DNA topoisomerase I inhibitors in cancer therapy.

  2003cited by this paper
• Lamellarin D: a novel potent inhibitor of topoisomerase I.

  2003cited by this paper
• Pre-mRNA splicing and human disease.

  2003cited by this paper
• Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing

  2003cited by this paper
• Liquid chromatographic separation of derivatives of diospyrin, a bioactive bisnaphthoquinonoid plant-product, and analogous naphthyl compounds.

  2003cited by this paper
• Antimycobacterial activity of diospyrin derivatives and a structural analogue of diospyrin against Mycobacterium tuberculosis in vitro.

  2003cited by this paper
• Phosphorylation-dependent control of the pre-mRNA splicing machinery.

  2003cited by this paper
• Homocamptothecins: potent topoisomerase I inhibitors and promising anticancer drugs.

  2003cited by this paper
• Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing.

  2003cited by this paper
• Isodiospyrin as a novel human DNA topoisomerase I inhibitor.

  2003influential reference
• Correction of disease-associated exon skipping by synthetic exon-specific activators

  2003cited by this paper
• Modulation of alternative splicing by antisense oligonucleotides.

  2003cited by this paper
• Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy.

  2003cited by this paper
• Listening to silence and understanding nonsense: exonic mutations that affect splicing

  2002cited by this paper
• Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins.

  2002cited by this paper
• Small Nuclear Ribonucleoprotein Remodeling During Catalytic Activation of the Spliceosome

  2002cited by this paper
• Induction of apoptosis in human cancer cell lines by diospyrin, a plant-derived bisnaphthoquinonoid, and its synthetic derivatives.

  2002cited by this paper
• Small Molecule DNA and RNA Binders

  2002cited by this paper
• Cellular roles of DNA topoisomerases: a molecular perspective

  2002cited by this paper
• The RNA splicing factor ASF/SF2 inhibits human topoisomerase I mediated DNA relaxation.

  2002influential reference
• Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients.

  2001cited by this paper
• DNA topoisomerases: structure, function, and mechanism.

  2001cited by this paper
• Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.

  2001cited by this paper
• Treatment of spinal muscular atrophy by sodium butyrate

  2001cited by this paper
• DNA relaxation and cleavage assays to study topoisomerase I inhibitors.

  2001cited by this paper
• DNA interaction of the tyrosine protein kinase inhibitor PD153035 and its N-methyl analogue.

  2001cited by this paper
• Effects of Atovaquone and Diospyrin-Based Drugs on the Cellular ATP of Pneumocystis carinii f. sp.carinii

  2000cited by this paper
• Effects of Atovaquone and Diospyrin-Based Drugs on Ubiquinone Biosynthesis in Pneumocystis carinii Organisms

  2000cited by this paper
• Topoisomerase I poisons and suppressors as anticancer drugs.

  2000cited by this paper
• Antibacterial activity of diospyrin, isodiospyrin and bisisodiospyrin from the root of Diospyros piscatoria (Gurke) (Ebenaceae)

  2000cited by this paper
• Synthesis of cytotoxic indenoisoquinoline topoisomerase I poisons.

  1999cited by this paper
• Recognition of exonic splicing enhancer sequences by the Drosophila splicing repressor RSF1.

  1999cited by this paper
• Binding of ATP to human DNA topoisomerase I resulting in an alteration of the conformation of the enzyme.

  1999influential reference
• Pharmacology and chemotaxonomy of Diospyros.

  1999cited by this paper
• Poisoning of topoisomerase I by an antitumor indolocarbazole drug: stabilization of topoisomerase I-DNA covalent complexes and specific inhibition of the protein kinase activity.

  1999cited by this paper
• Diospyrin, a bisnaphthoquinone: a novel inhibitor of type I DNA topoisomerase of Leishmania donovani.

  1998cited by this paper
• Interaction between the N-terminal domain of human DNA topoisomerase I and the arginine-serine domain of its substrate determines phosphorylation of SF2/ASF splicing factor.

  1998cited by this paper
• The C-terminal domain but not the tyrosine 723 of human DNA topoisomerase I active site contributes to kinase activity.

  1998cited by this paper
• Review article number 134 pharmacology and chemotaxonomy of diospyros

  1998cited by this paper
• DNA topoisomerase I: customs officer at the border between DNA and RNA worlds?

  1997cited by this paper
• In vitro Activity of Diospyrin and Derivatives against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei brucei

  1996cited by this paper
• Pharmacological Studies on the Effect of the Treatment of Swiss A Mice with Diospyrin, a Tumour‐inhibitory Plant Product, and its Synthetic Derivatives

  1996cited by this paper
• Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I

  1996cited by this paper
• In vitro antiplasmodial effects of diospyrin, a plant‐derived naphthoquinoid, and a novel series of derivatives

  1995cited by this paper
• Studis on changes in tumour-inhibitory activities through structural modification of a diospyrin derivative

  1994cited by this paper
• Isolation and Characterisation of Sulphur Compounds from Tulbaghia violacea

  1992cited by this paper
• Primary structure of the human splicing factor ASF reveals similarities with Drosophila regulators.

  1991cited by this paper
• Antiprotozoal activity of diospyrin towards Leishmania donovani promastigotes in vitro.

  1987cited by this paper
• Interactions between small nuclear ribonucleoprotein particles in formation of spliceosomes.

  1987cited by this paper
• A protein that specifically recognizes the 3' splice site of mammalian pre-mRNA introns is associated with a small nuclear ribonucleoprotein.

  1986cited by this paper
• Biological activity of diospyrin towards Ehrlich ascites carcinoma in Swiss A mice.

  1984cited by this paper

• Diospyrin: biosynthesis, distribution in the plant kingdom, and therapeutic potential

  2025cites this paper
• Analysis of Diospyrin: A Short Review

  2022cites this paper
• Many Voices in a Choir: Tumor-Induced Neurogenesis and Neuronal Driven Alternative Splicing Sound Like Suspects in Tumor Growth and Dissemination

  2021cites this paper
• RAD51 Inhibition Induces R-Loop Formation in Early G1 Phase of the Cell Cycle

  2021cites this paper
• Biology of the mRNA Splicing Machinery and Its Dysregulation in Cancer Providing Therapeutic Opportunities

  2021cites this paper
• RNA Splicing: Basic Aspects Underlie Antitumor Targeting.

  2020cites this paper
• DNA folds threaten genetic stability and can be leveraged for chemotherapy

  2020cites this paper
• Alternative‐splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics

  2018cites this paper
• The isoflavone fraction from soybean presents mRNA maturation inhibition activity

  2017cites this paper
• Modulating splicing with small molecular inhibitors of the spliceosome

  2017cites this paper
• Screening for small molecule inhibitors of HIV-1 Gag expression.

  2017cites this paper
• Identification of a small molecule inhibitor that stalls splicing at an early step of spliceosome activation

  2017cites this paper
• Splicing factor gene mutations in hematologic malignancies.

  2017cites this paper
• Inhibition of mRNA Maturation by Compounds Which Have a Flavonoid Skeleton

  2017cites this paper
• Phytochemicals With Antileishmanial Activity: Prospective Drug Targets

  2017cites this paper
• Chemotherapy induces alternative transcription and splicing: Facts and hopes for cancer treatment.

  2017cites this paper
• Identification of Novel Compounds That Inhibit HIV-1 Gene Expression by Targeting Viral RNA Processing

  2015cites this paper
• Non-quinolone inhibitors of bacterial type IIA topoisomerases: a feat of bioisosterism.

  2014cites this paper
• DNA damage triggers SAF-A and RNA biogenesis factors exclusion from chromatin coupled to R-loops removal

  2014cites this paper
• Tumor antigens as proteogenomic biomarkers in invasive ductal carcinomas

  2014cites this paper
• Senataxin, Defective in the Neurodegenerative Disorder Ataxia with Oculomotor Apraxia 2, Lies at the Interface of Transcription and the DNA Damage Response

  2012cites this paper
• Establishment of a Monitoring System to Detect Inhibition of mRNA Processing

  2012cites this paper
• A Quantitative High-Throughput In Vitro Splicing Assay Identifies Inhibitors of Spliceosome Catalysis

  2012cites this paper
• Molecular architecture of zinc chelating small molecules that inhibit spliceosome assembly at an early stage.

  2012cites this paper
• Interaction of small molecules with nucleic acid targets: From RNA secondary structure to the ribosome

  2012cites this paper
• Psoromic Acid Derivatives: A New Family of Small‐Molecule Pre‐mRNA Splicing Inhibitors Discovered by a Stage‐Specific High‐Throughput in Vitro Splicing Assay

  2012cites this paper
• Alternative splicing in human tumour viruses: a therapeutic target?

  2012cites this paper
• Alternative splicing interference by xenobiotics.

  2012cites this paper
• Alternative Splicing of Fibroblast Growth Factor Receptor IgIII Loops in Cancer

  2011cites this paper
• Protein-protein interactions and cancer: targeting the central dogma.

  2011cites this paper
• Secalonic acid D as a novel DNA topoisomerase I inhibitor from marine lichen-derived fungus Gliocladium sp. T31

  2011cites this paper
• Repair of pre-mRNA splicing

  2010cites this paper
• Dissecting the transcriptional functions of human DNA topoisomerase I by selective inhibitors: implications for physiological and therapeutic modulation of enzyme activity.

  2010cites this paper
• Development of Mycobacterium tuberculosis DNA gyrase as a target for antibacterial chemotherapy

  2010cites this paper
• The SR Protein B52/SRp55 Is Required for DNA Topoisomerase I Recruitment to Chromatin, mRNA Release and Transcription Shutdown

  2010cites this paper
• RECQ5 helicase associates with the C-terminal repeat domain of RNA polymerase II during productive elongation phase of transcription

  2010cites this paper
• Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription

  2009cites this paper
• Topoisomerase 1 suppresses replication stress and genomic instability by preventing interference between replication and transcription.

  2009cites this paper
• Small molecule inhibitors of yeast pre-mRNA splicing.

  2009cites this paper
• Selective induction of apoptosis by 7-methyljuglone, its derivatives and isolated compounds from Foeniculum vulgare Mill. on human cancer cells

  2009influential citation
• The spliceosome as target for anticancer treatment

  2008influential citation
• Regulation of splicing by protein phosphorylation.

  2008cites this paper
• Isolation and Characterization of Human Precatalytic Spliceosomal B Complexes

  2007cites this paper
• Development of a voltammetric sensor for diospyrin determination in nanomolar concentrations.

  2006cites this paper
• Le code de l'épissage et sa modulation thérapeutique par des molécules chimiques

  2005cites this paper
• [Selective modification of alternative splicing by indole derivatives that target SR protein splicing factors].

  2005cites this paper
• Alternative splicing: a new drug target of the post-genome era.

  2005cites this paper
• Des signaux mortels qui contrôlent la taille du cerveau

  2005cites this paper
• The spliceosome: a novel multi-faceted target for therapy.

  2005cites this paper